Ferretti Gianna, Bacchetti Tiziana, Nègre-Salvayre Anne, Salvayre Robert, Dousset Nicole, Curatola Giovanna
Institute of Biochemistry, Faculty of Medicine, University of Ancona, via Ranieri 1-60131, Italy.
Atherosclerosis. 2006 Jan;184(1):1-7. doi: 10.1016/j.atherosclerosis.2005.08.008. Epub 2005 Sep 12.
High density lipoproteins (HDL) are susceptible to structural modifications mediated by various mechanisms including oxidation, glycation, homocysteinylation or enzymatic degradation. Structural alterations of HDL may affect their functional and atheroprotective properties. Oxidants, such as hypochlorous acid, peroxyl radicals, metal ions, peroxynitrite, lipoxygenases and smoke extracts, can alter both surface and core components of HDL. The formation of lipid peroxidation derivatives, such as thiobarbituric acid reactive substances, conjugated dienes, lipid hydroperoxides and aldehydes, is associated with changes of physical properties (fluidity, molecular order) and of apoprotein conformation. Non-enzymatic glycation, generally associated with lipoxidation, leads to form irreversible complexes called advanced glycation end products. These HDL modifications are accompanied with altered biological activities of HDL and associated enzymes, including paraoxonase, CETP and LCAT. Homocysteine-induced modification of HDL is mediated by homocysteine-thiolactone, and can be prevented by a calcium-dependent thiolactonase/paraoxonase. Tyrosylation of HDL induces the formation of dimers and trimers of apo AI, and alters cholesterol efflux. Phospholipases and proteolytic enzymes can also modify HDL lipid and apoprotein structure. HDL modification induces generally the loss of their anti-inflammatory and cytoprotective properties. This could play a role in the pathogenesis of atherosclerosis and neurodegenerative diseases such as Alzheimer's disease.
高密度脂蛋白(HDL)易受多种机制介导的结构修饰影响,这些机制包括氧化、糖基化、同型半胱氨酸化或酶促降解。HDL的结构改变可能会影响其功能和抗动脉粥样硬化特性。氧化剂,如次氯酸、过氧自由基、金属离子、过氧亚硝酸盐、脂氧合酶和烟雾提取物,可改变HDL的表面和核心成分。脂质过氧化衍生物的形成,如硫代巴比妥酸反应性物质、共轭二烯、脂质氢过氧化物和醛,与物理性质(流动性、分子有序性)和载脂蛋白构象的变化有关。非酶糖基化通常与脂氧化相关,会导致形成不可逆的复合物,称为晚期糖基化终产物。这些HDL修饰伴随着HDL及相关酶(包括对氧磷酶、胆固醇酯转运蛋白和卵磷脂胆固醇酰基转移酶)生物学活性的改变。同型半胱氨酸诱导的HDL修饰由同型半胱氨酸硫内酯介导,可被钙依赖性硫内酯酶/对氧磷酶阻止。HDL的酪氨酰化会诱导载脂蛋白AI二聚体和三聚体的形成,并改变胆固醇流出。磷脂酶和蛋白水解酶也可修饰HDL的脂质和载脂蛋白结构。HDL修饰通常会导致其抗炎和细胞保护特性丧失。这可能在动脉粥样硬化和神经退行性疾病(如阿尔茨海默病)的发病机制中起作用。